OR-45 Pazhenkottil AP, Ghadri JR, Nkoulou RN, Wolfrum M, Buechel RR, Küest SM, Husmann L, Herzog BA, Gaemperli O, Kaufmann PA. Improved outcome prediction by SPECT myocardial perfusion imaging after CT attenuation correction. J Nucl Med. 2011 Feb;52(2):196 – 200. OR-46 Pazhenkottil AP, Buechel RR, Nkoulou R, Ghadri JR, Herzog BA, Husmann L, Wolfrum M, Küest SM, Fiechter M, Gaemperli O, Kaufmann PA. Left ventricular dyssynchrony assessment by phase analysis from gated PET-FDG scans. J Nucl Cardiol. 2011 Oct;18(5):920 – 5. OR-47 Pazhenkottil AP, Nkoulou RN, Ghadri JR, Herzog BA, Buechel RR, Küest SM, Wolfrum M, Fiechter M, Husmann L, Gaemperli O, Kaufmann PA. Prognostic value of cardiac hybrid imaging integrating single-photon emission computed tomography with coronary computed tomography angiography. Eur Heart J. 2011 Jun;32(12):1465 –71. OR-48 Rajapakse AG, Yepuri G, Carvas JM, Stein S, Matter CM, Scerri I, Ruffieux J, Montani JP, Ming XF, Yang Z. Hyperactive S6K1 mediates oxidative stress and endothelial dysfunction in aging: inhibition by resveratrol. PLoS One. 2011 Apr 22;6(4):e19237. OR-49 Rozenberg I, Sluka SH, Mocharla P, Hallenberg A, Rotzius P, Borén J, Kränkel N, Landmesser U, Borsig L, Lüscher TF, Eriksson EE, Tanner FC. Deletion of L-selectin increases atherosclerosis development in ApoE–/– mice. PLoS One. 2011;6(7):e21675. OR-50 Scharen E, Paul M, Lüscher TF, Corti R, Manka R. Evaluation of acute peri-myocarditis with cardiac magnetic resonance imaging. Cardiovascular Medicine. 2011; 14(9):266 – 268. OR-51 Scharf C, Krasniqi N, Hellermann J, Rahn M, Sütsch G, Brunckhorst C, Duru F. Electrical activation in the coronary sinus branches as a guide to cardiac resynchronisation therapy: rationale for a coordinate system. PLoS One. 2011;6(8):e19914. OR-52 Simic B, Hermann M, Shaw SG, Bigler L, Stal<strong>der</strong> U, Dörries C, Besler C, Lüscher TF, Ruschitzka F. Torcetrapib impairs endothelial function in hypertension. Eur Heart J. 2011 Sep 14. [Epub ahead of print] OR-53 Sonnenschein K, Horváth T, Mueller M, Markowski A, Siegmund T, Jacob C, Drexler H, Landmesser U. Exercise training improves in vivo endothelial repair capacity of early endothelial progenitor cells in subjects with metabolic syndrome. Eur J Cardiovasc Prev Rehabil. 2011 Jun;18(3):406 –14. OR-54 Sorrentino SA, Doerries C, Manes C, Speer T, Dessy C, Lobysheva I, Mohmand W, Akbar R, Bahlmann F, Besler C, Schaefer A, Hilfiker-Kleiner D, Lüscher TF, Balligand JL, Drexler H, Landmesser U. Nebivolol exerts beneficial effects on endothelial function, early endothelial progenitor cells, myocardial neovascularization, and left ventricular dysfunction early after myocardial infarction beyond conventional β1-blockade. J Am Coll Cardiol. 2011 Feb 1;57(5):601–11. OR-55 Stähli BE, Bünzli R, Grünenfel<strong>der</strong> J, Bühler I, Felix C, Bettex D, Biaggi P, Tanner FC, Nguyen-Kim DL, Plass A, Ge H, Falk V, Lüscher TF, Corti R, Maier W, Altwegg LA. Transcatheter aortic valve implantation (TAVI) outcome according to standardized endpoint definitions by the Valve Academic Research Consortium (VARC). J Invasive Cardiol. 2011 Aug;23(8):307–12. OR-56 Stefanini GG, Kalesan B, Serruys PW, Heg D, Buszman P, Linke A, Ischinger T, Klauss V, Eberli F, Wijns W, Morice MC, Di Mario C, Corti R, Antoni D, Sohn HY, Eerdmans P, van Es GA, Meier B, Windecker S, Jüni P. Long-term clinical outcomes of biodegradable polymer biolimus-eluting stents versus durable polymer sirolimus-eluting stents in patients with coronary artery disease (LEADERS): 4 year follow-up of a randomised non-inferiority trial. Lancet. 2011 Dec 3;378(9807):1940 – 8. OR-57 Steffel J, Milosevic G, Hürlimann A, Krasniqi N, Namdar M, Ruschitzka F, Lüscher TF, Duru F, Holzmeister J, Hürlimann D. Characteristics and long-term outcome of echocardiographic super-respon<strong>der</strong>s to cardiac resynchronisation therapy: ‹real world› experience from a single tertiary care centre. Heart. 2011 Oct;97(20):1668 –74. OR-58 Steffel J, Hürlimann D, Namdar M, Despotovic D, Kobza R, Wolber T, Holzmeister J, Haegeli L, Brunckhorst C, Lüscher TF, Jenni R, Duru F. Long-term follow-up of patients with isolated left ventricular noncompaction: role of electrocardiography in predicting poor outcome. Circ J. 2011;75(7):1728 – 34. OR-59 Templin C, Lüscher TF, Landmesser U. Cell-based cardiovascular repair and regeneration in acute myocardial infarction and chronic ischemic cardiomyopathy-current status and future developments. Int J Dev Biol. 2011;55(4-5):407–17. OR-60 Toggweiler S, Borst O, Enseleit F, Hermann M, Ruschitzka F, Lüscher TF, Noll G. NT-proBNP provides incremental prognostic information in cardiac outpatients with and without echocardiographic findings. Clin Cardiol. 2011 Mar;34(3):183 – 8. OR-61 Vaccarino V, Badimon L, Corti R, de Wit C, Dorobantu M, Hall A, Koller A, Marzilli M, Pries A, Bugiardini R; Working Group on Coronary Pathophysiology and Microcirculation. Ischaemic heart disease in women: are there sex differences in pathophysiology and risk factors ? Position paper from the working group on coronary pathophysiology and microcirculation of the European Society of Cardiology. Cardiovasc Res. 2011 Apr 1;90(1):9 –17. OR-62 Valenta I, Landmesser U, Schindler TH. Vascular function of the peripheral and coronary circulation: worthwhile to assess their relation ? J Nucl Cardiol. 2011 Apr;18(2):201– 3. OR-63 Vitanis V, Manka R, Giese D, Pe<strong>der</strong>sen H, Plein S, Boesiger P, Kozerke S. High resolution three-dimensional cardiac perfusion imaging using compartment-based k-t principal component analysis. Magn Reson Med. 2011 Feb;65(2):575 – 87. OR-64 Wilkoff BL, Bello D, Taborsky M, Vymazal J, Kanal E, Heuer H, Hecking K, Johnson WB, Young W, Ramza B, Akhtar N, Kuepper B, Hunold P, Luechinger R, Puererfellner H, Duru F, Gotte MJ, Sutton R, Sommer T; EnRhythm MRI SureScan Pacing System Study Investigators. Magnetic resonance imaging in patients with a pacemaker system designed for the magnetic resonance environment. Heart Rhythm. 2011 Jan;8(1):65 –73. OR-65 Winnik S, Lohmann C, Richter EK, Schäfer N, Song WL, Leiber F, Mocharla P, Hofmann J, Klingenberg R, Borén J, Becher B, Fitzgerald GA, Lüscher TF, Matter CM, Beer JH. Dietary α-linolenic acid diminishes experimental atherogenesis and restricts T cell-driven inflammation. Eur Heart J. 2011 Oct;32(20):2573 – 84. OR-66 Wolber T, Haegeli L, Huerlimann D, Brunckhorst C, Lüscher TF, Duru F. Altered left ventricular contraction pattern during right ventricular pacing: assessment using real-time three-dimensional echocardiography. Pacing Clin Electrophysiol. 2011 Jan;34(1):76 – 81. OR-67 Yonekawa K, Neidhart M, Altwegg LA, Wyss CA, Corti R, Vogl T, Grigorian M, Gay S, Lüscher TF, Maier W. Myeloid related proteins activate Toll-like receptor 4 in human acute coronary syndromes. Atherosclerosis. 2011 Oct;218(2):486 – 92. The complete list of publications of the Division of Cardiology can be downloaded from the following open source repository and archive: www.zora.uzh.ch Die vollständige Publikationsliste <strong>der</strong> <strong>Klinik</strong> für <strong>Kardiologie</strong> finden Sie unter: www.zora.uzh.ch
Education und Research Sponsoren 2011 / 12 Private Donationen Legat Evelyne Ingold, Genève Legat Hedwig Braun, Bern Alfred Reimann, Zürich Ruth Forster-Ruck, Zürich Ernst Theodor Henne, Zollikon Albin Murer, Beckenried Stiftungen Desirée and Niels Yde Foundation, Zürich Fondation Leducq, Paris Herzog Egli Stiftung, Zürich Regula Stiftung, Nie<strong>der</strong>hasli Schweizerische Herzstiftung, Bern Uniscientia Stiftung, Vaduz Institutionelle Donationen Abbott Vascular AG, Baar Actelion Pharma Schweiz AG, Baden AstraZeneca AG, Zug Axis-Shield AG, Wädenswil Bard Medica S.A., Oberrieden Bayer Healthcare (Schweiz) AG, Zürich Biomed AG, Dübendorf Biosensors Europe SA, Morges Biotronik Schweiz AG, Baar Boehringer Ingelheim (Schweiz) GmbH, Basel Boston Scientific AG, Solothurn B. Braun Medical AG, Sempach Bracco Suisse SA, Mendrisio Daiichi-Sankyo (Schweiz) AG, Thalwil Deva Holding, Istanbul, Türkei Diatools AG, Villmergen Edwards Lifesciences AG, Horw Eli Lilly (Suisse) SA, Vernier European Society of Cardiology, Sophia Antipolis, Frankreich EuroVascLtd., Zürich GE Healthcare AG, Glattbrugg Genzyme Europe B.V., Naarden, Holland GlaxoSmithKline AG, Münchenbuchsee Healthworld (Schweiz) AG, Steinhausen Hospitalis-Verlag AG, Zürich Icon Clinical Research, Dublin, Irland Invatec Technology GmbH, Frauenfeld Johnson & Johnson AG (Biosense Webster), Spreitenbach Labormedizinisches Zentrum Dr. Risch, Kloten Mars Symbioscience, Rockville, USA MCM medsys AG, Kirchberg Meda Pharma GmbH, Wangen-Brüttisellen Medtronic (Schweiz) AG, Münchenbuchsee Medtronic Bakken Research, Maastricht, Holland A. Menarini AG, Zürich Merck Sharp & Dohme-Chibret AG, Luzern Novartis Pharma Schweiz AG, Bern Orion Pharma AG, Zug Pfizer AG, Zürich Pfizer International Inc., New York, USA Philips AG, Medical Systems, Zürich PPD Germany GmbH, München Robapharm AG, Allschwil Roche Diagnostics (Schweiz) AG, Rotkreuz Roche Pharma (Schweiz) AG, Reinach Sanofi Aventis (Suisse) SA, Meyrin / Genf Sarstedt AG, Sevelen SG Schiller-Reomed AG, Dietikon Schweiz. Gesellschaft für <strong>Kardiologie</strong>, Bern Servier (Suisse) SA, Meyrin / Genf Siemens Schweiz AG, Zürich Sirtris (GSK), El Paso, USA Sorin Group International AG, Lausanne St. Jude Medical AG, Zürich Swiss Life AG, Zürich Takeda Pharma AG, Lachen Terumo (Deutschland) GmbH, Spreitenbach The Medicines Company (Schweiz) GmbH, Kloten Vifor (International) AG, St. Gallen Kreativ-Team <strong>Jahresbericht</strong> 2011 Sabine Krebs, lic. phil. (links) Direktionsassistentin Prof. Thomas F. Lüscher Michaela Keel, M. Sc. (rechts) Koordinatorin Leducq Netzwerk
Change language